Ponsegromab for the Treatment of Cancer Cachexia.
(2025) The New England journal of medicine — Vol. 392, n° 10, p. 1035 (2025)
Files
2025_Dufour_N_Engl_J_Med.pdf
Open Access - Adobe PDF
- 313.47 KB
Details
- Authors
- Abstract
- To the Editor: Groarke et al. (Dec. 19/26 issue)report on the efficacy and safety of ponsegromab for cancer-related cachexia in patients with elevated levels of growth differentiation factor 15 (GDF-15). [...]
- Affiliations
Citations
Dufour, I., Bindels, L., & Goffin, E. (2025). Ponsegromab for the Treatment of Cancer Cachexia. The New England journal of medicine, 392(10), 1035. https://doi.org/10.1056/NEJMc2500502 (Original work published 2025)